Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

5-adamantylpentanoic acid (2-(4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxy)ethyl)(methyl)amide MeSH Supplementary Concept Data 2025


MeSH Supplementary
5-adamantylpentanoic acid (2-(4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxy)ethyl)(methyl)amide
Unique ID
C507231
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C507231
Entry Term(s)
BP 1107
BP-1107
BP1107
Registry Numbers
0
Heading Mapped to
Adamantane / analogs & derivatives
*Thiazolidinediones
Frequency
1
Note
has antipsoriatic activity; structure in first source
Source
J Pharmacol Exp Ther 2005 Dec;315(3):996-1004
Date of Entry
2006/01/22
Revision Date
2006/01/22
5-adamantylpentanoic acid (2-(4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxy)ethyl)(methyl)amide Preferred
BP 1107 Narrower
page delivered in 0.005s